149 related articles for article (PubMed ID: 24258339)
1. Isotretinoin and pregnancy prevention: do we need to take a long, hard look at ourselves?
Altman EM
JAMA Dermatol; 2014 Apr; 150(4):361-2. PubMed ID: 24258339
[No Abstract] [Full Text] [Related]
2. Women's experiences with isotretinoin risk reduction counseling.
Werner CA; Papic MJ; Ferris LK; Lee JK; Borrero S; Prevost N; Schwarz EB
JAMA Dermatol; 2014 Apr; 150(4):366-71. PubMed ID: 24258663
[TBL] [Abstract][Full Text] [Related]
3. We Pledge to Change iPLEDGE.
Pierson JC; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
[No Abstract] [Full Text] [Related]
4. Oral isotretinoin and pregnancy prevention programmes.
Thiboutot D; Gollnick H; Bettoli V; Dréno B; Kang S; Leyden JJ; Shalita A; Torres V;
Br J Dermatol; 2012 Feb; 166(2):466-7; author reply 467-8. PubMed ID: 21985025
[No Abstract] [Full Text] [Related]
5. Promoting safe use of isotretinoin by increasing contraceptive knowledge.
Leger MC
JAMA Dermatol; 2015 Apr; 151(4):393-4. PubMed ID: 25651501
[No Abstract] [Full Text] [Related]
6. Simplifying contraception requirements for iPLEDGE: A decision analysis.
Barbieri JS; Roe AH; Mostaghimi A
J Am Acad Dermatol; 2020 Jul; 83(1):104-108. PubMed ID: 32068040
[TBL] [Abstract][Full Text] [Related]
7. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
[TBL] [Abstract][Full Text] [Related]
8. A survey of pregnant women using isotretinoin.
Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
[TBL] [Abstract][Full Text] [Related]
9. Promoting safe use of isotretinoin by increasing contraceptive knowledge.
Werner CA; Papic MJ; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Apr; 151(4):389-93. PubMed ID: 25650743
[TBL] [Abstract][Full Text] [Related]
10. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A
Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721
[No Abstract] [Full Text] [Related]
11. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin and iPledge: a view of results.
Maloney ME; Stone SP
J Am Acad Dermatol; 2011 Aug; 65(2):418-419. PubMed ID: 21763564
[No Abstract] [Full Text] [Related]
13. A call for action--prevention of fetal exposure to isotretinoin. A position paper by The Organization of Teratology Information Services Public Affairs Committee.
Carver V; Coyle B; Koren G; Lavigne S; Martinez L; Robertson J; Polifka J; Stepanuk K;
Reprod Toxicol; 2001; 15(6):729. PubMed ID: 11738527
[No Abstract] [Full Text] [Related]
14. Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.
Crijns I; Straus S; Luteijn M; Gispen-de Wied C; Raine J; de Jong-van den Berg L
Drug Saf; 2012 Jan; 35(1):27-32. PubMed ID: 22050373
[TBL] [Abstract][Full Text] [Related]
15. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster.
Atanackovic G; Koren G
Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298
[TBL] [Abstract][Full Text] [Related]
16. Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin.
Fain K; Alexander GC
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1258-62. PubMed ID: 24115318
[No Abstract] [Full Text] [Related]
17. Patient-physician-regulator triad.
Valois M; Peterson R; Bouthillier L
CMAJ; 2005 Jan; 172(1):15; author reply 18. PubMed ID: 15632390
[No Abstract] [Full Text] [Related]
18. Comments on: are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin.
Van Bennekom CM; Mitchell AA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):439. PubMed ID: 24706419
[No Abstract] [Full Text] [Related]
19. Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin.
Fain K; Alexander GC
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):440-1. PubMed ID: 24706420
[No Abstract] [Full Text] [Related]
20. Accutane registry compulsory in US, but not Canada.
Andresen M
CMAJ; 2006 Jun; 174(12):1701. PubMed ID: 16754892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
